259 related articles for article (PubMed ID: 24612427)
21. A comparison of recombinant thrombin to bovine thrombin as a hemostatic ancillary in patients undergoing peripheral arterial bypass and arteriovenous graft procedures.
Weaver FA; Lew W; Granke K; Yonehiro L; Delange B; Alexander WA;
J Vasc Surg; 2008 Jun; 47(6):1266-73. PubMed ID: 18440754
[TBL] [Abstract][Full Text] [Related]
22. The use of desmopressin in congenital factor XI deficiency: a systematic review.
Franchini M; Manzato F; Salvagno GL; Montagnana M; Lippi G
Ann Hematol; 2009 Oct; 88(10):931-5. PubMed ID: 19609524
[TBL] [Abstract][Full Text] [Related]
23. Recombinant activated factor VII and tranexamic acid are haemostatically effective during major surgery in factor XI-deficient patients with inhibitor antibodies.
Livnat T; Tamarin I; Mor Y; Winckler H; Horowitz Z; Korianski Y; Bar-Zakay B; Seligsohn U; Salomon O
Thromb Haemost; 2009 Sep; 102(3):487-92. PubMed ID: 19718468
[TBL] [Abstract][Full Text] [Related]
24. [Familial study of factor XI deficiency. Presurgical prophylactic treatment with desmopressin plus antifibrinolytics].
García Fernández JR; Sánchez Forte M; Diego Fernández Pd; López Berenguel F; Moreno Madrid F
An Esp Pediatr; 2002 Oct; 57(4):373-7. PubMed ID: 12392675
[TBL] [Abstract][Full Text] [Related]
25. Dental procedures in adult patients with hereditary bleeding disorders: 10 years experience in three Italian Hemophilia Centers.
Franchini M; Rossetti G; Tagliaferri A; Pattacini C; Pozzoli D; Lorenz C; Del Dot L; Ugolotti G; Dell'aringa C; Gandini G
Haemophilia; 2005 Sep; 11(5):504-9. PubMed ID: 16128895
[TBL] [Abstract][Full Text] [Related]
26. [Strategy for secure hemostasis in hemophilia patients undergoing surgery for malignant neoplasms].
Szczepanik AB; Wisławski S; Windyga J; Huszcza S; Bilski R; Meissner AJ
Pol Merkur Lekarski; 2009 Nov; 27(161):375-80. PubMed ID: 19999800
[TBL] [Abstract][Full Text] [Related]
27. The management of postoperative bleeding.
Dagi TF
Surg Clin North Am; 2005 Dec; 85(6):1191-213, x. PubMed ID: 16326202
[TBL] [Abstract][Full Text] [Related]
28. Reduction of blood loss using high-dose aprotinin in major orthopaedic surgery.
Slappendel R; Dirksen R; Van Hellemondt GG
J Bone Joint Surg Br; 2004 May; 86(4):620; author reply 620-1. PubMed ID: 15174566
[No Abstract] [Full Text] [Related]
29. Consensus recommendations for the use of FEIBA(®) in haemophilia A patients with inhibitors undergoing elective orthopaedic and non-orthopaedic surgery.
Rangarajan S; Austin S; Goddard NJ; Négrier C; Rodriguez-Merchan EC; Stephensen D; Yee TT
Haemophilia; 2013 Mar; 19(2):294-303. PubMed ID: 22989234
[TBL] [Abstract][Full Text] [Related]
30. Management of hemorrhage in cardiothoracic surgery.
Görlinger K; Shore-Lesserson L; Dirkmann D; Hanke AA; Rahe-Meyer N; Tanaka KA
J Cardiothorac Vasc Anesth; 2013 Aug; 27(4 Suppl):S20-34. PubMed ID: 23910533
[TBL] [Abstract][Full Text] [Related]
31. Which is more effective in adolescent idiopathic scoliosis surgery: batroxobin, tranexamic acid or a combination?
Xu C; Wu A; Yue Y
Arch Orthop Trauma Surg; 2012 Jan; 132(1):25-31. PubMed ID: 21909815
[TBL] [Abstract][Full Text] [Related]
32. A Clinico-pathologic Study of Oxidized Cellulose as Topical Hemostatic Agent in Neurosurgery.
Gazzeri R; Neroni M; Pischedda M; Martin M; Galarza M; Campagna D; Giordano M
Surg Technol Int; 2015 May; 26():376-81. PubMed ID: 26055035
[TBL] [Abstract][Full Text] [Related]
33. Central nervous system bleeding in patients with rare bleeding disorders.
Siboni SM; Zanon E; Sottilotta G; Consonni D; Castaman G; Mikovic D; Biondo F; Tagliaferri A; Iorio A; Mannucci PM; Peyvandi F
Haemophilia; 2012 Jan; 18(1):34-8. PubMed ID: 21539694
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic plasma exchange for perioperative management of patients with congenital factor XI deficiency.
Alsammak MS; Ashrani AA; Winters JL; Pruthi RK
J Clin Apher; 2017 Dec; 32(6):429-436. PubMed ID: 28295573
[TBL] [Abstract][Full Text] [Related]
35. Coagulation challenges after severe injury with hemorrhagic shock.
Ledgerwood AM; Blaisdell W
J Trauma Acute Care Surg; 2012 Jun; 72(6):1714-8. PubMed ID: 22695446
[TBL] [Abstract][Full Text] [Related]
36. Experience with Optivate®, a new high purity concentrate of factor VIII with von Willebrand factor, in patients undergoing surgery.
Hay CR; Hellmann A; Dmoszynska A; Baglin T; O'Shaunessey D; Makris M; Shaikh-Zaidi R; Dash CH
Haemophilia; 2011 May; 17(3):428-32. PubMed ID: 21371182
[TBL] [Abstract][Full Text] [Related]
37. Hemostasis in oral surgery.
Kamoh A; Swantek J
Dent Clin North Am; 2012 Jan; 56(1):17-23, vii. PubMed ID: 22117940
[TBL] [Abstract][Full Text] [Related]
38. [Mouth-washing with tranexamic acid in patients treated with oral anticoagulants subjected to oral surgery procedures].
Bernardoni-Socorro C; Arteaga-Vizcaino M; Villamizar Y; Diez-Ewald M; Vizcaíno-Salazar G; Torres-Guerra E; Quintero J
Invest Clin; 1998 Jun; 39(2):77-83. PubMed ID: 9707919
[TBL] [Abstract][Full Text] [Related]
39. No increased bleeding risk for oral surgery in patients with severe congenital bleeding disorders due to intense perioperative management.
Goldmann G; Berens C; Marquardt N; Reich R; Oldenburg J; Wenghoefer M
Oral Maxillofac Surg; 2015 Jun; 19(2):195-200. PubMed ID: 25488716
[TBL] [Abstract][Full Text] [Related]
40. Impaired thrombin generation and fibrin clot formation in patients with dilutional coagulopathy during major surgery.
Schols SE; Lancé MD; Feijge MA; Damoiseaux J; Marcus MA; Hamulyák K; Ten Cate H; Heemskerk JW; van Pampus EC
Thromb Haemost; 2010 Feb; 103(2):318-28. PubMed ID: 20024495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
